interval. Then the lower of the two measurements was used as the blood pressure. Although this method is not common for epidemiologic studies, it is common for health checkups for workers. The purpose of this method is to evaluate whether each subject has hypertension or not. Further, this method is based on the recommendation from the Japanese Association for Cerebro-cardiovascular Disease control, 21 basically. Because it seemed to provide the information of which equal to use the second of two measurements and better than use the mean of two measurements, this method was employed for our studies.
Body Mass Index (BMI), body weight in kilogram divided by squared height in meter, was used as a measure of body composition.
Blood samples were drawn into disposable plastic vacuum tubes (Becton, sst gel and clot activator) from a peripheral vein. Serum total cholesterol (TC) and fasting blood sugar (FBS) were measured using an autoanalyzer (Model 7150 Autoanalyzer, Hitachi). TC and FBS were determined enzymatically using commercial enzyme kits (cholesterol oxidase method, Kyowa Medex, Tokyo, Japan, and Hexokinase glucose 6 phosphatedehydrogenase method, Wako, Tokyo, Japan, respectively).
Alcohol drinking and smoking habits were assessed using a questionnaire on lifestyle factors.
Endothelin-1 gene polymorphism Ala288Ser
The ET-1 gene polymorphism studied here was selected from released polymorphisms 20 according to variation in the exon loci where the protein is encoded. The present study is the first report to examine the association between this polymorphism and hypertension.
Identification of polymorphism
Genome DNA was extracted using a fully automatic nucleic acid extractor (MagExtractor Genome, Toyobo Co., Ltd., Osaka, Japan). The extracted genome DNA was stored at -20 until genotyping. The polymerase chain reaction confronting two pair primers method (PCR-CTPP) 22 was used to analyze the Ala288Ser polymorphism in the ET-1 gene. The design of 4 primers for PCR-CTPP in the franking region of the G/T polymorphism associated with the Ala288Ser polymorphism in the ET-1 gene was as follows: the forward primer was 5'-CCT CGC TCC CAT TCT AAG CAT AGG G-3', the reverse primer was 5'-CCT TTG CCA GTC AGG AAC CA-3', the G allele-specific forward primer was 5'-GAT CCC AAG CTG AAA GGC AAG-3', and the T allelespecific reverse primer was 5'-TCA CAT AAC GCT CTC TGG AGG GA-3'. PCR was performed in a thermal cycler (i-cycler, Bio-rad., CA, USA). The total volume of PCR reaction solution was 10 ml for each sample, containing 2 mmol/L of each primer. The solution contained 10 mmol/L Tris-HCl (pH 8.3), 50 mmol/L KCl, 1.5 mmol/L MgCl2, 250 mmol/L of each dNTP, and 5U of AmpliTaq Gold DNA polymerase (Applied Biosystems, New Jersey, USA). For the PCR procedure, initial denaturation for 10 min at 95 was subsequent to a hot start at 95 . Following the ET-1 Ala288Ser and Hypertension formed as case-control association studies. 6, [13] [14] [15] [16] [17] [18] Moreover, the relationship between a polymorphism in the ET-1 gene and ventricular arrhythmia has been reported. 19 Although the presence of a novel polymorphism, the G/T polymorphism with an amino acid substitution (Ala to Ser) at codon 288 in exon 5 at position 862 of the ET-1 gene (Ala288Ser), was released, 20 the prevalence of the polymorphism among general population was not available. In this way, the presence of a novel human ET-1 gene polymorphism was revealed, but the relationship between the polymorphism and hypertension was not available.
Thus, in the present study, we analyzed the relationship between the novel ET-1 gene polymorphism and hypertension among Japanese workers. To assess the relationship more detail than in previous reports, a retrospective cohort study enrolling lifestyle factors as considerable variables was performed.
Study population and eligible cohort subjects
The study population was recruited from workers of a company who received annual health checkups and gave written informed consent in 1998, in Shimane Prefecture in Western Japan. The total number of the study population was 1,978. Among the study population of our study, 1,175 subjects were received annual health checkups in both 1992 and 1998. The number of subjects who assessed as normotensive was 975, after excluding hypertensive in 1992, sat as a study cohort. Because there were 922 subjects whose various variables for this study were known, 95% of normotensives in 1992 were enrolled in this study as eligible cohort subject. The incidence of hypertension was assessed at the health checkups in 1998. The following selection criteria for hypertension were applied both in 1992 and 1998: (1) hypertension was defined by systolic blood pressure (SBP) of 140 mmHg and over and/or diastolic blood pressure (DBP) of 90 mmHg and over; or (2) subject received medication for hypertension. The eligible subjects were divided into two groups by incidence of hypertension (i.e., hypertensive and normotensive in 1998). The number of subjects who developed the hypertension in 1998 was 133, 14.4% of the eligible subjects. Among the 133 incident cases, 128 subjects were assessed based on their blood pressure in 1998. Further, 111 subjects showed SBP less than 160 mmHg and/or DBP less than 100 mmHg.
Various measurements and survey of life habits
Blood pressure was measured with the subjects seated, on the right arm, using a standard mercury sphygmomanometer after at least 5 minutes of rest subsequent to urination. Phase I and phase V Korotkov sounds were recorded as SBP and DBP, respectively. Blood pressure was measured once for each subject, when SBP was less than 140 mmHg and DBP was under 90 mmHg. In case of SBP with 140 mmHg and higher and/or DBP with 90 mmHg and higher, re-measure was performed after at least 5 minute TC, FBS, alcohol drinking and smoking habits.
The distribution of the Ala288Ser polymorphism in the ET-1 gene among Japanese workers was revealed by the present study; the Ala/Ala, Ala/Ser, and Ser/Ser genotypes were in 49%, 41%, and 10% of subjects, respectively. The Ser allele frequency showed a high proportion at 30%. On the other hand, with both univariate and multivariate analysis adjusted for considerable variables, the polymorphism showed no statistical significance for the incidence of hypertension.
As far as we know, seven studies that assessed the relationship between ET-1 polymorphism and hypertension have been published. The first study reported no effect for a Taq1 restriction fragment length polymorphism on hypertension and blood pressure level. 13 Stevens et al. 14 and Brown et al. 16 studied on single base insertion of adenine at position 138 in the ET-1 gene, and showed the association between the polymorphism and DBP among control subjects with normal blood pressure. The remaining four reports studied the Lys198Asn polymorphism in the ET-1 gene. Among them, a study of pregnant women revealed that the Lys/Asn and Asn/Asn genotypes significantly raised SBP compared to the Lys/Lys genotype during pregnancy, and the effect disappeared after delivery. 6 Other three studies on the polymorphism were population-based. 15, 17, 18 These three reports demonstrated that a steeper increase in blood pressure with BMI occurred in obese subjects with this polymorphism, without distinction of race.
There have been no reports available on the Ala288Ser polymorphism in the ET-1 gene, which we studied here, yet. A high proportion of 30% of the Ser allele frequency in this polymorphism was observed. Although no association between the polymorphism and incidence of hypertension was observed after adjusting for confounding factors including lifestyle variables, additional studies are needed to examine the mean of this polymorphism.
The relationship was analyzed, and adjusted for FBS and lifestyle variables as well as sex, age, BMI, and TC, in this study. Participation of insulin in the modulation of plasma ET-1 levels was suspected. 28, 29 It is also known that a higher concentration of serum insulin is observed in obese subjects. 30, 31 Thus, FBS was included in the analysis to adjust for the confounding factor of insulin resistance of subjects. Moreover, in the epidemiologic knowledge, chronic exposure to smoking would not increase the risk of incidence of hypertension. 32 Regarding plasma ET-1 levels, some reports have demonstrated an increase by smoking, 33, 34 whereas another has reported a decrease. 35 On the other hand, alcohol drinking has been shown to increase the risk of incidence of hypertension. 36 Regarding plasma ET-1 levels, one study has demonstrated no induction by alcohol drinking. 37 The polymorphism studied in this report did not seem to be a candidate gene responsible for incidence of hypertension because it showed no Kaetsu A, et al.
PCR cycle with denaturation for 30 sec at 95 , annealing for 30 sec at 65 , and polymerization for 60 sec at 72 was performed 35 times. Samples for electrophoresis were prepared with 4.0 ml of PCR product and 0.4 ml of Loading Buffer (Wako Pure Chemical Industries, Ltd., Osaka, Japan). The samples were electrophoresed in 6% polyacrylamide gels and DNA was visualized by ethidium bromide staining for genotype assessment.
Statistical analysis
The SAS ® software (SAS Institute, Cary, NC) was employed for all statistical analysis. Unpaired analysis of results by a Wilcoxon rank sum test was performed to assess whether differences of quantitative variables between normotensives and hypertensives were significant. Chi-square tests were calculated to evaluate the distribution and trend of sex, lifestyle and genotype. The odds ratios (OR) and 95% confidence intervals (CI) of each factor for incidence of hypertension were estimated by univariate and multivariate unconditional logistic regression analysis. Statistical significance was defined as p<0.05.
Ethical issue
The present study was approved by the Ethics Committee of the Faculty of Medicine, Tottori University (No.81. 2000, and No.128. 2001). [23] [24] [25] [26] [27] Informed consent of gene analysis was obtained from each study subject.
Sex distribution, mean value and standard deviation (SD) of age and various quantitative variables, and distribution of lifestyle factors at the health checkups in 1992 by incidence of hypertension in 1998 are shown in Table 1 . The proportion of incident cases of hypertension was larger in males than in females. Mean values of age, BMI, TC, and FBS were higher in hypertensives than in normotensives, respectively. The proportions of incident cases of hypertension were larger in alcohol drinkers and smokers than in nondrinkers and nonsmokers. Similar trends were observed in subjects' age under 40 years, and 40+, respectively.
The distributions of genotype and allele frequency are shown in Table 2 . The relative frequencies of Ala/Ala, Ala/Ser, and Ser/Ser genotypes were 49%, 41%, and 10%, respectively. The allele frequencies were 70% and 30% for Ala and Ser alleles, respectively. These results are consistent with the Hardy-Weinberg equilibrium. Neither the genotype nor the allele frequency showed statistical significance between incidences of hypertension. Similar trends were observed in subjects' age under 40 years, and 40+, respectively.
The relationships between genotype, allele frequency and incidence of hypertension estimated by unconditional logistic regression analysis are shown in Table 3 . The OR of Ala/Ser and Ser/Ser against Ala/Ala by univariate analysis in whole subjects showed a lower trend, but was not significant. The possibility that relations and siblings showed similar characteristics and influenced the results cannot be denied. Fourth, the accuracy of the record of health checkups is listed. Lifestyle variables were surveyed, through interview by public health nurses, based on a self-statement by each subject. The presence of recall bias is suspected. A prospective cohort study should be performed for a more exact evaluation.
In our results, in neither univariate analysis nor multivariate analysis after adjusting for considerable variables did the Ala288Ser polymorphism in the ET-1 gene show a statistically significant relationship with incidence of hypertension. The Ala288Ser polymorphism in the ET-1 gene did not seem to be a candidate gene responsible for incidence of hypertension among these study subjects. All the reports which have studied the relationship between polymorphism in the ET-1 gene and hypertension were analyzed using case-control association studies. A retrospective cohort study among workers, not hospital-based, was employed in this study. Although a cohort study was employed to reduce the effect of biases, compared to the case-control study, some limitations remain in this investigation. First, for the incident cases of hypertension in this study, we are not able to deny the possibility that they included cases of secondary hypertension. However, the influence of this limitation is thought to be small, since more than 90% of Japanese hypertension cases are essential hypertension. 38 Second, the influence of our definition of incidence of hypertension. Although 133 subjects developed hypertension in 1998, many of them were assessed based on their blood pressure and showed mild hypertension. The Blood pressure was measured carefully, however, because of the individual variation and other biases 39 in blood pressure, there is possibility that our definition of incidence of hypertension leads the overestimation of the number of incident cases and results the underestimation of the relationship between the polymorphism and incidence of hypertension. Third, the relationships among study subjects were not confirmed. 
